Budapest-based Turbine adds €5.5 million to uncover novel cancer therapies with cell simulation and machine learning

Published on June 20, 2023

Turbine, a company that uses cell simulations to guide biopharma R&D and bring the right drug to every patient in need, has successfully added €5.5 million from MassMutual Ventures (MMV) to its recently closed Series A financing round. This investment brings the company’s oversubscribed Series A round to €25.5 million and adds further U.S.-based investors…

This content is for members only. Visit the site and log in/register to read.

The post Budapest-based Turbine adds €5.5 million to uncover novel cancer therapies with cell simulation and machine learning appeared first on EU-Startups.